Whereas, according to recent studies, tumor cells can avoid the immune response by utilizing various immune checkpoints, which can play a crucial part in cancer immunotherapy, including programmed death-1 (PD1), PDL1, and CTLA4. The gene discussed is CTLA4; the disease is cancer.